Our partners at Novartis recently provided the following letter regarding their study of the medication Alpelisib (Vijoice) for the treatment of PROS, called EPIK-P4, in the hopes that the PROS community finds the information helpful and relevant. CSC is sharing the letter with you on their behalf. A few reminders from Novartis about this letter:
.
Cloves Syndrome CommunitySupport. Research. Education.